In what may be one of the most important HIV research breakthroughs in years, scientists have discovered a strikingly ...
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...
Researchers showed that people treated with fostemsavir have lower levels of “bad” antibodies produced in response to a HIV ...
The Brighterside of News on MSN
Scientists re-engineer a patient’s own T cells to target and destroy cancer cells
Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...
Accurate monitoring of CD4 + T cell counts is vital for evaluating immune health and guiding treatment in people living with Human Immunodeficiency Virus (HIV). Yet conventional tools like flow ...
HuMax-CD4 is in Phase III trials for CTCL and Phase II studies for PTCL. TenX Biopharma negotiated a deal with $4.5 million up front for exclusive, worldwide rights to develop and commercialize Genmab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback